Investments
57Portfolio Exits
22Funds
6About Galen Partners
Galen Partners is a private equity financing firm. The firm focuses on growth equity investments in health care technology-enabled services, medical devices, and specialty pharmaceutical companies.
Want to inform investors similar to Galen Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Galen Partners News
Sep 13, 2023
Philip Borden, a venture capitalist with roots at Galen Partners, Oxford Bioscience Partners and Frazier Healthcare Partners, took a majority stake in the shared lab space company with private equity firm Pacific Lake Partners and is looking to expand through Greater Boston.
Galen Partners Investments
57 Investments
Galen Partners has made 57 investments. Their latest investment was in CDx Diagnostics as part of their Recap on July 7, 2017.
Galen Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
7/11/2017 | Recap | CDx Diagnostics | Yes | 3 | ||
4/12/2016 | Series C | Ajinomoto Cambrooke | No | 4 | ||
5/28/2015 | Series D | Life Image | $17.5M | No | 4 | |
7/29/2013 | Unattributed VC - III | |||||
4/18/2013 | Series C |
Date | 7/11/2017 | 4/12/2016 | 5/28/2015 | 7/29/2013 | 4/18/2013 |
|---|---|---|---|---|---|
Round | Recap | Series C | Series D | Unattributed VC - III | Series C |
Company | CDx Diagnostics | Ajinomoto Cambrooke | Life Image | ||
Amount | $17.5M | ||||
New? | Yes | No | No | ||
Co-Investors | |||||
Sources | 3 | 4 | 4 |
Galen Partners Portfolio Exits
22 Portfolio Exits
Galen Partners has 22 portfolio exits. Their latest portfolio exit was Life Image on September 15, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
9/15/2022 | Acquired | 10 | |||
7/1/2021 | Reverse Merger | 4 | |||
4/27/2021 | Acquired | 10 | |||
Date | 9/15/2022 | 7/1/2021 | 4/27/2021 | ||
|---|---|---|---|---|---|
Exit | Acquired | Reverse Merger | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 10 | 4 | 10 |
Galen Partners Acquisitions
2 Acquisitions
Galen Partners acquired 2 companies. Their latest acquisition was Evolve Treatment Centers on January 08, 2020.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/8/2020 | Acq - Fin | 2 | ||||
12/10/2003 | Series A |
Date | 1/8/2020 | 12/10/2003 |
|---|---|---|
Investment Stage | Series A | |
Companies | ||
Valuation | ||
Total Funding | ||
Note | Acq - Fin | |
Sources | 2 |
Galen Partners Fund History
6 Fund Histories
Galen Partners has 6 funds, including Galen Evolve SPV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
10/15/2019 | Galen Evolve SPV | $20M | 1 | ||
10/15/2019 | Galen Partners VI Annex Fund | ||||
7/20/2017 | Galen CDx SPV II | ||||
7/20/2017 | Galen CDx SPV III | ||||
7/20/2017 | Galen CDx SPV |
Closing Date | 10/15/2019 | 10/15/2019 | 7/20/2017 | 7/20/2017 | 7/20/2017 |
|---|---|---|---|---|---|
Fund | Galen Evolve SPV | Galen Partners VI Annex Fund | Galen CDx SPV II | Galen CDx SPV III | Galen CDx SPV |
Fund Type | |||||
Status | |||||
Amount | $20M | ||||
Sources | 1 |
Galen Partners Team
8 Team Members
Galen Partners has 8 team members, including , .
Name | Work History | Title | Status |
|---|---|---|---|
Judith Starkey | Founder | Current | |
Name | Judith Starkey | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Founder | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
